Inactivation of infectious pathogens in labile blood components: meeting the challenge
L Corash - Transfusion clinique et biologique, 2001 - Elsevier
Substantial improvement in the safety of blood transfusion has been achieved through the
addition of new tests, such as nucleic acid tests, yet residual risk associated with transfusion …
addition of new tests, such as nucleic acid tests, yet residual risk associated with transfusion …
[引用][C] Inactivation of infectious pathogens in labile blood components: meeting the challenge
L CORASH - Transfusion clinique et biologique (Paris), 2001 - pascal-francis.inist.fr
Inactivation of infectious pathogens in labile blood components : meeting the challenge CNRS
Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …
Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …
Inactivation of infectious pathogens in labile blood components: meeting the challenge
L Corash - Transfusion clinique et biologique, 2001 - infona.pl
Substantial improvement in the safety of blood transfusion has been achieved through the
addition of new tests, such as nucleic acid tests, yet residual risk associated with transfusion …
addition of new tests, such as nucleic acid tests, yet residual risk associated with transfusion …
Inactivation of infectious pathogens in labile blood components: meeting the challenge.
L Corash - Transfusion Clinique et Biologique: Journal de la …, 2001 - europepmc.org
Substantial improvement in the safety of blood transfusion has been achieved through the
addition of new tests, such as nucleic acid tests, yet residual risk associated with transfusion …
addition of new tests, such as nucleic acid tests, yet residual risk associated with transfusion …
Inactivation of infectious pathogens in labile blood components: meeting the challenge
L Corash - Transfusion clinique et biologique: journal de …, 2001 - pubmed.ncbi.nlm.nih.gov
Substantial improvement in the safety of blood transfusion has been achieved through the
addition of new tests, such as nucleic acid tests, yet residual risk associated with transfusion …
addition of new tests, such as nucleic acid tests, yet residual risk associated with transfusion …
Inactivation of infectious pathogens in labile blood components: meeting the challenge
L Corash - Transfusion clinique et biologique, 2001 - infona.pl
Substantial improvement in the safety of blood transfusion has been achieved through the
addition of new tests, such as nucleic acid tests, yet residual risk associated with transfusion …
addition of new tests, such as nucleic acid tests, yet residual risk associated with transfusion …